[Post-sclerotherapy pigmentation].
D006801:Humans; D010859:Pigmentation Disorders / Q000139:chemically induced*; D012597:Sclerosing Solutions / Q000009:adverse effects*; D014648:Varicose Veins / Q000188:drug therapy*
D012597:Sclerosing Solutions
Pigmentations post-sclérothérapiques